JIYI ACUPUNCTURE INTERNATIONAL CLINICAL RESEARCH COMMITTEE LTD

15 WOLLATON STREET, NOTTINGHAM  NG1 5FW
  • Active - Proposal to Strike off
  • PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
  • Company No. 12228433
  • Last Updated: 01 Oct 2022

Company Profile

JIYI ACUPUNCTURE INTERNATIONAL CLINICAL RESEARCH COMMITTEE LTD was incorporated on Thursday, September 26, 2019 as a PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) with registered address in NOTTINGHAM. JIYI ACUPUNCTURE INTERNATIONAL CLINICAL RESEARCH COMMITTEE LTD has the status: Active - Proposal to Strike off and it's listed in the following category: Activities of professional membership organizations. This PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) has been operating for 4 years 11 months and 29 days.

Name JIYI ACUPUNCTURE INTERNATIONAL CLINICAL RESEARCH COMMITTEE LTD
Company number 12228433
Company type PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Incorporation date 26 Sep 2019
Status Active - Proposal to Strike off
Industry (SIC 2007)

Address

Registered Address 15 WOLLATON STREET
NOTTINGHAM
NG1 5FW
Country Of Origin UNITED KINGDOM

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Dr Chaolong Liu Nationality: Chinese Dates: Thursday, September 26, 2019 - present
voting rights 75 to 100 percent
right to appoint and remove directors

Accounts and Confirmation

Type of accounts DORMANT
End of financial Year 30 September
Next annual accounts due 30 June 2022, (-818 days left)
Latest accounts 30 September 2020
Next confirmation statement due 24 October 2020
Last confirmation statement dated Not available

Mortgages

No mortgages have been registered against JIYI ACUPUNCTURE INTERNATIONAL CLINICAL RESEARCH COMMITTEE LTD.

Previous Names

Name Change Date
JIYI ACUPUNCTURE INTERNATIONAL CLINICAL RESEARCH COMMITTEE LTD 26 Sep 2019